Alloantigen recognition is critical for CD8 T cell-mediated graft anti-tumor activity against murine BCL1 lymphoma after myeloablative bone marrow transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/17603512

Download in:

View as

General Info

PMID
17603512